SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001052918-20-000180
Filing Date
2020-07-23
Accepted
2020-07-23 08:00:18
Documents
6
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 AVRICORE HEALTH INC. FORM 6K avricore6ksept2019.htm 6-K 7575
2 NEWS RELEASE ex99-1.htm EX-99 14560
3 ex9911.jpg GRAPHIC 9592
4 ex9912.jpg GRAPHIC 37856
5 ex9913.jpg GRAPHIC 36299
6 ex9914.jpg GRAPHIC 18042
  Complete submission text file 0001052918-20-000180.txt   164064
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-51848 | Film No.: 201042768
SIC: 2834 Pharmaceutical Preparations